Display Settings:

Format

Send to:

Choose Destination
    Am J Psychiatry. 1987 Aug;144(8):1071-3.

    An open trial of L-tyrosine in the treatment of attention deficit disorder, residual type.

    Abstract

    To elucidate the role of catecholamines in attention deficit disorder, the authors conducted an open 8-week trial of L-tyrosine in 12 adults with attention deficit disorder, residual type. Eight showed marked to moderate clinical response in 2 weeks; at 6 weeks these eight developed tolerance, suggesting that L-tyrosine is not useful in attention deficit disorder, residual type.

    PMID:
    3300376
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk